These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 32035102

  • 1. Cell cycle regulators in cancer cell metabolism.
    Leal-Esteban LC, Fajas L.
    Biochim Biophys Acta Mol Basis Dis; 2020 May 01; 1866(5):165715. PubMed ID: 32035102
    [Abstract] [Full Text] [Related]

  • 2. The multifaceted role of cell cycle regulators in the coordination of growth and metabolism.
    Huber K, Mestres-Arenas A, Fajas L, Leal-Esteban LC.
    FEBS J; 2021 Jun 01; 288(12):3813-3833. PubMed ID: 33030287
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Molecular systems biology of Sic1 in yeast cell cycle regulation through multiscale modeling.
    Barberis M.
    Adv Exp Med Biol; 2012 Jun 01; 736():135-67. PubMed ID: 22161326
    [Abstract] [Full Text] [Related]

  • 8. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
    Roskoski R.
    Pharmacol Res; 2016 May 01; 107():249-275. PubMed ID: 26995305
    [Abstract] [Full Text] [Related]

  • 9. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D, Ortega S.
    Front Biosci; 2006 Jan 01; 11():1164-88. PubMed ID: 16146805
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J.
    Cancer Radiother; 2001 Apr 01; 5(2):109-29. PubMed ID: 11355576
    [Abstract] [Full Text] [Related]

  • 15. Metabolic adaptation to cancer growth: from the cell to the organism.
    Escoté X, Fajas L.
    Cancer Lett; 2015 Jan 28; 356(2 Pt A):171-5. PubMed ID: 24709629
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Induction of UGT1A1 and CYP2B6 by an antimitogenic factor in HepG2 cells is mediated through suppression of cyclin-dependent kinase 2 activity: cell cycle-dependent expression.
    Sugatani J, Osabe M, Kurosawa M, Kitamura N, Ikari A, Miwa M.
    Drug Metab Dispos; 2010 Jan 28; 38(1):177-86. PubMed ID: 19797611
    [Abstract] [Full Text] [Related]

  • 18. Cell-cycle control and plant development.
    Inagaki S, Umeda M.
    Int Rev Cell Mol Biol; 2011 Jan 28; 291():227-61. PubMed ID: 22017978
    [Abstract] [Full Text] [Related]

  • 19. New Insights into CDK Regulators: Novel Opportunities for Cancer Therapy.
    Bury M, Le Calvé B, Ferbeyre G, Blank V, Lessard F.
    Trends Cell Biol; 2021 May 28; 31(5):331-344. PubMed ID: 33676803
    [Abstract] [Full Text] [Related]

  • 20. Whether to target single or multiple CDKs for therapy? That is the question.
    Węsierska-Gądek J, Maurer M, Zulehner N, Komina O.
    J Cell Physiol; 2011 Feb 28; 226(2):341-9. PubMed ID: 20836132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.